Table 1.
Antigen | Route of Delivery | Species | Immune Effects | References | |
---|---|---|---|---|---|
Antigen-specific induction | MDA-LDL Copper-oxidized LDL |
Subcutaneous + Freund’s adjuvant |
Rabbit | Increased auto-antibodies titers | [97,98] |
apoB-derived peptides | Subcutaneous | Apoe−/− mice | Increased Foxp3+ Tregs Decreased Th1 and Th2 signature |
[101] | |
apoB-derived peptides | Subcutaneous + Freund’s adjuvant |
Apoe−/− mice | Increased Foxp3+ CCR5+Tregs Increased IL-10 production |
[100] | |
Ox- and MDA-LDL | Oral route | Ldlr−/− mice | Increased Foxp3+Tregs Increased TGF-β production |
[102] | |
apoB-derived peptide (aBp210) | Subcutaneous + Alum |
Apoe−/− mice | Increased Foxp3+ CD25+ Tregs Decreased Th1 and Th2 signature |
[104] | |
ApoB100 | Loaded on DC stimulated by IL-10 |
HuB100(tg) X Ldlr−/− mice |
Decreased T effector proliferation Decreased Th1 signature |
[91] | |
HSP 60 | Oral route | Ldlr−/− mice | Increased Foxp3+ CD25+Tregs Increased IL-10, TGF-β production |
[103] | |
ApoB100 peptide + HSP60 peptide + Chlamydophila pneumoniae peptide |
Subcutaneous + Alum |
Apobtm2Sgy
Ldlr tm1Her J mice |
Increased Foxp3+ CD4+ T cells Increased IL-10 and TGF-β production Decreased IFN-γ and TNF-α production |
[105] | |
Non-antigen specific induction | Anti-CD3 alone or combined with IL-2 | Intravenous | Ldlr−/− mice | Increased Foxp3+Tregs Decreased IFN-γ and TNF-α production |
[106] |
Anti-CD3 | Oral route | Apoe−/− mice | Increased Foxp3+Tregs Decreased Th1 and Th2 signature Increased TGF-β production |
[107] | |
G-CSF | Subcutaneous | Apoe−/− mice | Increased CD4+ CD25+Tregs | [108] | |
vitamin D3 | Oral route | Apoe−/− mice | Increased Foxp3+Tregs Decreased CD80+CD86+ DC Increased IL-10 production |
[109] | |
FTY720 | Oral route | Apoe−/− mice | Increased LAP+Foxp3+ cells Decreased Th1 signature Increased TGF-β production |
[110] | |
Nucleoprotein of measles virus | Intraperitoneal | Apoe−/− mice | Decreased T effector proliferation Decreased Th1 signature Increased IL-10 production |
[111] | |
Low IL-2 | Intravenous | Apoe−/− mice | Increased Foxp3+ CD25+ Tregs | [112] | |
Intraperitoneal | Ldlr−/− mice | Increased Foxp3+ CD25+ Tregs Decreased Th1 and Th2 signature |
[113] | ||
Intraperitoneal | Apoe−/− mice | Increased Foxp3+ CD25+ Tregs Decreased Th1, Th2, Th17 signature |
[114] |